Quapat 0.2% Eye Drop
By Quapat
Rx
5ml Eye Drop in a Bottle

Composition
Olopatadine(0.2% w/v)

Manufacturer - Raymed Pharmaceuticals Ltd
SCO 859, NAC Manimajra, Chandigarh-160101

Expires on or after
September, 2025

liver
No interaction has been found or established between Quapat 0.2% Eye Drop and liver function. It is important to note that there is no specific safety advice related to liver issues available for this medication. You can use Quapat 0.2% Eye Drop as prescribed without significant concerns regarding its impact on liver health. If you have any specific liver concerns or conditions, it is advisable to consult with your doctor for personalized guidance before using this medication.

kidney
No interaction found/established regarding kidney issues with Quapat 0.2% Eye Drop.

alcohol
No interaction found between alcohol and Quapat 0.2% Eye Drop.

driving
After using Quapat 0.2% Eye Drop, your vision may be blurry temporarily. Avoid driving until your vision is clear to ensure safety on the road.

pregnancy
Quapat 0.2% Eye Drop may not be safe during pregnancy. Limited human studies and animal research suggest potential harm to the baby. Your doctor will assess the benefits and risks before prescribing. Consult your doctor for guidance.

breastfeeding
Quapat 0.2% Eye Drop is considered safe for breastfeeding. Minimal data indicates no major risks for the baby.
Habit Forming | No |
Chemical Class | Dibenzoxepine Derivative |
Therapeutic Class | - |
Action Class | H1 Antihistaminics (second Generation) |
₹200
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024